Literature DB >> 29138041

Attendance at Prescribed Pelvic Floor Physical Therapy in a Diverse, Urban Urogynecology Population.

Megan B Shannon1,2,3, Madeleine Genereux1,2,3, Cynthia Brincat1,2,3, William Adams1,2,3, Linda Brubaker1,2,3, Elizabeth R Mueller1,2,3, Colleen M Fitzgerald1,2,3.   

Abstract

BACKGROUND: Pelvic floor physical therapy (PFPT) is a common and effective treatment for several pelvic floor disorders, but there is limited knowledge about adherence to the therapy or what factors influence attendance.
OBJECTIVE: To determine rates of PFPT attendance (initiation and completion) as well as correlates of PFPT attendance.
DESIGN: Retrospective cohort analysis.
SETTING: Urban outpatient clinics at a tertiary medical center treating women with pelvic floor disorders. PARTICIPANTS: Patients prescribed PFPT during the time period January 1, 2014, through January 1, 2015. MAIN OUTCOME MEASUREMENTS: Number of PFPT visits recommended and attended; diagnoses associated with PFPT referral.
RESULTS: Two-thirds of participants (66%; 118/180) initiated PFPT but less than one-third (29%; 52/180) completed the full treatment course. On univariate analysis, age, body mass index, diagnosis requiring PFPT treatment, marital or employment status, insurance type, number of comorbidities, incontinence status on examination, and stage of prolapse did not differ between PFPT initiators and noninitiators. Those who self-identified as Hispanic were less likely to initiate PFPT when compared with non-Hispanic patients, although this only trended toward significance (odds ratio 0.40, 95% confidence interval 0.14-1.09; exact P = .078).
CONCLUSIONS: Two-thirds (66%) of patients initiated PFPT but less than one-third (29%) completed the treatment course. There appears to be an opportunity to augment PFPT attendance, as well as explore racial disparities in attendance. LEVEL OF EVIDENCE: II.
Copyright © 2018 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29138041     DOI: 10.1016/j.pmrj.2017.11.008

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  7 in total

1.  Better together: multidisciplinary approach improves adherence to pelvic floor physical therapy.

Authors:  Heidi W Brown; Hayley C Barnes; Amy Lim; Dobie L Giles; Sarah E McAchran
Journal:  Int Urogynecol J       Date:  2019-08-28       Impact factor: 2.894

2.  Factors Associated With Nonadherence to Pelvic Floor Physical Therapy Referral for the Treatment of Pelvic Pain in Women.

Authors:  Frank Aguirre; Jessica Heft; Amanda Yunker
Journal:  Phys Ther       Date:  2019-07-01

3.  Why Patients Fall Through the Cracks: Assessment of Patients' Overactive Bladder Treatment.

Authors:  Emily R W Davidson; Lia Miceli; Katie Propst
Journal:  J Womens Health (Larchmt)       Date:  2022-03-29       Impact factor: 3.017

4.  Comparison of Pelvic Floor Physical Therapy Attendance Based on Referring Provider Specialty.

Authors:  Morgan E Fullerton; Patricia J Mwesigwa; Megha D Tandel; Lorna Kwan; Tamara Grisales; Christopher M Tarnay
Journal:  Female Pelvic Med Reconstr Surg       Date:  2022-01-01       Impact factor: 1.913

5.  Retrospective claims analysis of physical therapy utilization among women with stress or mixed urinary incontinence.

Authors:  Jessica L McKinney; Manasi Datar; Li-Chen Pan; Thomas Goss; Laura E Keyser; Samantha J Pulliam
Journal:  Neurourol Urodyn       Date:  2022-03-30       Impact factor: 2.367

6.  Patient and economic benefits of psychological support for noncompliant patients.

Authors:  Phil Reed; Lisa A Osborne; C Mair Whittall; Simon Emery; Roberto Truzoli
Journal:  Front Psychol       Date:  2022-09-15

7.  The Use of Ancillary Services Under a Bundled Care Versus a Fee-For-Service Payment Model.

Authors:  Lauren Caldwell; Gabriela E Halder; Stephanie Nutt; Rebecca G Rogers; Michelle L Wright; Audrey Baum; Amanda B White
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-08-01       Impact factor: 1.913

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.